Journal of Clinical Psychopharmacology

Current Issue

January/February 2019 - Volume 39 - Issue 1

Editor-in-Chief: Richard I. Shader, MD
David J. Greenblatt, MD
ISSN: 0271-0749
Online ISSN: 1533-712X
Frequency: 6 issues / year
Ranking: Psychiatry 50/142; Pharmacy and Pharmacology 85/261
Impact Factor: 3.134

Guest Editorials

Why Do You Keep Telling Me That Drug-Drug Interactions Are Important in Psychopharmacology When I Do Not See Them in My Clinical Practice?: My Failure to Convince Clinicians

de Leon, Jose

Journal of Clinical Psychopharmacology. 39(1):1-4, January/February 2019.

Commentary

Statistics Commentary Series: Commentary No. 30: Propensity Scores

Streiner, David L.

Journal of Clinical Psychopharmacology. 39(1):9-12, January/February 2019.

Original Contributions

Effect of Brexpiprazole on Prolactin: An Analysis of Short- and Long-Term Studies in Schizophrenia

Ivkovic, Jelena; Lindsten, Annika; George, Vinu; More

Journal of Clinical Psychopharmacology. 39(1):13-19, January/February 2019.

Editors’ Note

Editors’ Note: Retraction Notice

Journal of Clinical Psychopharmacology. 39(1):45, January/February 2019.

Brief Reports

Switching to Imipramine Versus Add-on Mirtazapine in Venlafaxine-Resistant Major Depression: A 10-Week Randomized Open Study

Navarro, Víctor; Boulahfa, Ilham; Obach, Amadeu; More

Journal of Clinical Psychopharmacology. 39(1):63-66, January/February 2019.

Letters to the Editors — Case Reports

Clozapine Addition Following Brain Surgery in Severe Primary Obsessive-Compulsive Disorder With Tardive Movement Disorder

Baptista, Trino; Araujo, Hilarión; de Leon, Jose

Journal of Clinical Psychopharmacology. 39(1):86-87, January/February 2019.

Mitchell B. Balter Award

The annual Balter Award was established in memory of Mitchell B. Balter, Ph.D. to recognize reports of outstanding investigations that reflect the principles embodied in Dr. Balter’s research on pharmacoepidemiology. The award-winning articles are now part of the JCP Collections.

Journal Logo

Secondary Logo